Brainsway (BWAY) Cash from Discontinued Operations (2020 - 2022)
Brainsway (BWAY) posted quarterly Cash from Discontinued Operations of 2987000.0 for Q1 2022, down 848.25% year-on-year from 399196.01 in Q1 2021, and down 183.6% on a QoQ basis from 3573000.0 in Q4 2021.
Brainsway (BWAY) Cash from Discontinued Operations (2020 - 2022) Analysis & Trends
Brainsway (BWAY) has reported Cash from Discontinued Operations for 3 consecutive years, with 2987000.0 the latest figure, recorded in Q1 2022.
- Quarterly Cash from Discontinued Operations fell 848.25% year-over-year to 2987000.0 in Q1 2022, while the trailing twelve-month figure through Mar 2022 was 1788000.0 (down 316.46% YoY) and the FY2021 annual result came in at 884000.0, up 161.56% from the prior year.
- Cash from Discontinued Operations declined to 2987000.0 in Q1 2022 per BWAY's latest filing, from 3573000.0 in the prior quarter.
- Over the last five years, Cash from Discontinued Operations for BWAY reached as high as 3573000.0 in Q4 2021 and fell as low as 2987000.0 in Q1 2022.
- A 3-year average of 120250.0 and a median of 435000.0 in 2021 frame the typical range for Cash from Discontinued Operations.
- Annual changes were most pronounced in 2021 — Cash from Discontinued Operations jumped 117.87% — and 2022, when it slumped 848.25%.
- Year by year, Cash from Discontinued Operations stood at 1640000.0 in 2020, then soared by 117.87% to 3573000.0 in 2021, then sank by 183.6% to 2987000.0 in 2022.
- According to Business Quant data, Cash from Discontinued Operations over the past three periods registered 2987000.0, 3573000.0, and 555000.0 for Q1 2022, Q4 2021, and Q3 2021 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.94 Bn | 176.64 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.78 Bn | 125.90 Bn | 3.81 Bn | - |
| 3 | Medtronic | 109.01 Bn | 99.79 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 68.59 Bn | 67.13 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 47.66 Bn | 43.99 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 28.36 Bn | 26.07 Bn | 1.98 Bn | - |
| 7 | Dexcom | 28.30 Bn | 27.18 Bn | 750.30 Mn | - |
| 8 | Smith & Nephew | 26.93 Bn | 26.36 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn | - |
| 10 | Brainsway | 593.65 Mn | 533.87 Mn | 11.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | -2.99 Mn |
| Mar 31, 2022 | -2.99 Mn |
| Dec 31, 2021 | 3.57 Mn |
| Dec 31, 2021 | 3.57 Mn |
| Sep 30, 2021 | -555,000.00 |
| Sep 30, 2021 | -555,000.00 |
| Jun 30, 2021 | -1.82 Mn |
| Jun 30, 2021 | -1.82 Mn |
| Mar 31, 2021 | -315,000.00 |
| Mar 31, 2021 | -315,000.00 |
| Dec 31, 2020 | 1.64 Mn |
| Dec 31, 2020 | 1.64 Mn |
| Sep 30, 2020 | -1.12 Mn |
| Sep 30, 2020 | -1.12 Mn |
| Jun 30, 2020 | 616,000.00 |
| Jun 30, 2020 | 616,000.00 |